Drug Report History #65191
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v3-FR | Version v1-EN |
|---|---|---|
| Language | French (Updated) | English |
| Date Updated | 2018-10-22 | 2018-10-22 |
| Drug Identification Number | 02271931 (Updated) | 02374749 |
| Brand name | ACT ZOPICLONE (Updated) | ACT RIZATRIPTAN ODT |
| Common or Proper name | ZOPICLONE (Updated) | RIZATRIPTAN OD |
| Company Name | ACTAVIS PHARMA COMPANY | ACTAVIS PHARMA COMPANY |
| Ingredients | ZOPICLONE (Updated) | RIZATRIPTAN |
| Strength(s) | 5MG (Updated) | 10MG |
| Dosage form(s) | TABLET (Updated) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL | ORAL |
| Packaging size | 100 (Updated) | 12 |
| ATC code | N05CF (Updated) | N02CC |
| ATC description | HYPNOTICS AND SEDATIVES (Updated) | ANTIMIGRAINE PREPARATIONS |
| Reason for discontinuation | Business reasons | Business reasons |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2018-04-30 (Updated) | 2018-03-30 |
| Remaining supply date | 2018-04-30 (Updated) | 2018-03-30 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | No | No |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | Transitioned. TEVA available | Transitioned. TEVA available |
| Health Canada comments |